Related by context. All words. (Click for frequent words.) 74 AMPAKINE compounds 66 Bicifadine 65 melanocortin receptor agonists 64 Tasimelteon 63 Panzem R 63 metaglidasen 63 Aganocide 63 Pancreate 63 PDE4 inhibitor 63 IMiDs R 63 selective androgen receptor modulator 63 Lixivaptan 62 AMPAKINE 62 selective androgen receptor modulators 62 torsemide ER 62 LibiGel ® 62 midstage clinical 62 rxRNA 61 Archexin 61 tiapamil 61 hypoxia selective 61 vascular disrupting agent 61 Aganocide R 61 oral prodrug 61 Androxal TM 61 ATL# [001] 61 Xcytrin R 61 Aganocide ® 61 Clonicel 61 JAK inhibitor 61 novel immunomodulatory 61 Vilazodone 61 Aviptadil 61 neuro inflammatory 60 defensin mimetic antibiotic 60 nicotinic alpha 7 60 PDE# inhibitors 60 CB2 selective 60 Factor VIIa 60 PNP inhibitor 60 PHX# 60 Plicera 60 pharmacological chaperone 60 SARMs 60 sulfonylhydrazine class 60 CCR9 antagonist 60 MTP inhibitor 60 Milnacipran 60 Anavex #-# 60 epothilone 60 romazarit 60 Cannabinor 60 intranasal formulation 60 immune modulating 60 targeted radiotherapeutic 60 peripherally acting 60 vinca alkaloid 60 JAK2 inhibitor 60 TELINTRA 60 epigenetic therapies 60 CINOD 60 Squalamine 59 Onconase 59 Curaxins 59 BEMA TM Fentanyl 59 atacicept 59 endothelin receptor antagonists 59 PDE7 59 gallium containing 59 ICA # 59 IMiDs ® 59 Guanilib 59 nalbuphine ER 59 Adnectin 59 PXD# 59 TRO# 59 R#/MEM 59 insulin sensitizer 59 glucokinase activator 59 IAP inhibitors 59 Zemiva TM 59 Serdaxin 59 EP #R 59 MEK inhibitor 59 R#/MEM # 59 adrenergic regulation 59 immuno inflammatory 59 NNRs 59 ALN PCS 59 Maxy G# 59 AMPAKINE CX# 59 vascular disrupting agents 59 Symadex 59 PDE# 59 Valdoxan 59 RNA antagonists 59 Cetrorelix 59 allosteric modulator 59 SGLT Inhibitors 59 Tß4 59 PDX pralatrexate 59 allosteric modulation 59 antiinfective 59 Personalized Immunotherapy 59 IMiDs ® compound 59 Phenoptin 59 Posiphen TM 59 Pimavanserin 59 IAP inhibitor 59 PDE7 inhibitors 59 targeting PCSK9 59 FOLOTYN ® 59 Ceflatonin R 59 tasimelteon 59 investigational humanized monoclonal antibody 59 PLK1 SNALP 59 TBC# 58 MAXY G# 58 molecular imaging radiopharmaceutical 58 tezampanel 58 Pyridorin 58 tranilast 58 Alzhemed TM 58 HGS# 58 Panzem 58 AEGR 58 Davanat 58 novel peptides 58 opioid antagonists 58 Marqibo TM 58 #ME# 58 Mipomersen 58 resolvins 58 Surfaxin LS 58 Syntonix 58 acadesine 58 SNT MC# 58 JAK1 58 THR beta agonist 58 Neo Kidney Augment 58 Tyrima 58 TLR antagonists 58 Sudhir Agrawal D.Phil 58 Cethrin R 58 anticoagulant reversing agent 58 therapeutic monoclonal antibody 58 Triolex 58 Spiegelmer ® 58 Zybrestat 58 anti secretory 58 Apoptone 58 Nanobody ® 58 5 HT2C 58 proteasome inhibitor 58 HQK 58 CORT # 58 HCV protease inhibitors 58 mitogen activated ERK kinase 58 immune modulation 58 HepeX B 58 LymphoStat B TM 58 Janus Kinase 58 vilazodone 58 isoform selective 58 novel anti infective 58 adrenal steroid hormones 58 Nanobody 58 teplizumab 58 antisense inhibitors 58 partial agonist 58 GPR# agonists 58 REG1 58 CB2 selective receptor agonist 58 ALN TTR 58 HepDirect 58 INS# [001] 58 prostone 58 neuroprotective properties 58 immune modulatory 58 Epothilones 58 ANAVEX #-# [003] 58 histone deacetylase HDAC 58 Solulin 58 neuronal nicotinic receptors NNRs 58 liposomal formulation 58 investigational hepatitis C 58 Stapled Peptide 58 PSN# [002] 58 INCB# [001] 58 MAXY VII 57 bicifadine 57 BNC# 57 small molecule defensin 57 JAK inhibitors 57 TLK# 57 commercialize lorcaserin 57 EVIZON TM squalamine lactate 57 insulin sensitizing 57 lomitapide 57 diabetic neuropathic pain 57 forodesine 57 CINQUIL 57 Anidulafungin 57 reslizumab 57 bardoxolone 57 thalidomide Thalomid 57 histone deacetylase HDAC inhibitor 57 glucagon receptor 57 Solazed TM 57 ONCONASE R 57 kidney urologic 57 ibudilast 57 CXB# 57 Adenosine Therapeutics 57 oxidative stress inducer 57 Lisofylline LSF 57 eniluracil 57 HDL Mimetic Peptide 57 HCV protease inhibitor 57 immuno modulatory 57 SinuNase ™ 57 cytostatic 57 SAR# [004] 57 potentiator 57 virus HCV protease inhibitor 57 Rebif ® 57 AEG# 57 Preclinical studies suggest 57 PI3K/mTOR 57 systemic RNAi 57 adipiplon 57 Cloretazine 57 DNA RNA Medicines 57 alvespimycin 57 adenosine A2A 57 Zoraxel 57 Annamycin 57 PSN# [001] 57 Targeted Chemotherapy 57 CB1 antagonists 57 GGF2 57 insulin sensitizers 57 Hedgehog agonist 57 PEG SN# 57 Prodarsan ® 57 preclinical 57 Exelixis compounds 57 COX Inhibiting Nitric Oxide 57 antiarrhythmic 57 Aurora kinase inhibitors 57 cathepsin K inhibitor 57 Curaxin 57 TKM ApoB 57 anti amnesic 57 Azedra TM 57 TÎ ² 4 57 Corlux 57 Exherin TM 57 candidate CRLX# 57 PKC# 57 ATL/TV# 57 Cloretazine R 57 prokinetic agent 57 oral immunomodulatory 57 nucleoside analog 57 exon skipping 57 OvaRex ® MAb 57 PRT# 57 High Impact AMPAKINE 57 dexanabinol 57 CB2 receptor selective 57 GSK# [002] 57 Celator 57 Viprinex 57 Talabostat 57 ALGRX 57 investigational monoclonal antibody 57 nitric oxide donating prostaglandin 57 elotuzumab 57 Onalta 57 PRX # 56 Elesclomol 56 immunomodulating 56 sodium glucose transporter 56 HuLuc# 56 fipamezole 56 Chemokine Therapeutics 56 oral talactoferrin 56 telomerase therapeutic 56 polymer conjugate technology 56 MEK inhibitors 56 synthetic retinoid 56 YONDELIS 56 YONDELIS R 56 TLR9 agonist 56 PS# [001] 56 ENMD # 56 Fodosine 56 TLR Therapeutics 56 SYN# 56 Fx #A 56 NGX# 56 Delta opioid receptor 56 Protexia ® 56 ELND# 56 protein tyrosine phosphatases 56 alagebrium 56 potent anticancer 56 Rigel R# 56 serotonin norepinephrine reuptake inhibitor 56 Pathway Inhibitor 56 phosphodiesterase inhibitors 56 tezampanel NGX# 56 HGS ETR2 56 HuMax CD4 56 ProSavin 56 Sulonex TM 56 OXIGON TM 56 Avicena 56 highly selective inhibitor 56 triphendiol 56 Chimigen TM 56 SRT# [003] 56 incyclinide 56 Perforomist ™ Inhalation Solution 56 AERx iDMS 56 gamma secretase inhibitor 56 non nucleoside HCV 56 ATL# [002] 56 therapeutic monoclonal antibodies 56 Xanafide 56 XmAb 56 telomerase inhibitor drug 56 CBLC# 56 DPX Survivac 56 synthetic siRNA 56 sodium thiosulfate STS 56 CK # novel 56 PF # [002] 56 Amigal 56 nucleoside tide 56 PrevOnco 56 CEQ# 56 nitric oxide donating 56 dacetuzumab 56 Lu AA# 56 Hedgehog antagonist 56 Hybridon 56 naltrexone hydrochloride 56 PEGylated interferon 56 Factor Xa inhibitor 56 Urocortin 2 56 Cethrin 56 QuatRx 56 molecular chaperone 56 HCV antiviral 56 MGCD# [001] 56 dirucotide 56 obatoclax 56 GPR# agonist 56 Selzentry Celsentri 56 HCV polymerase 56 XL# XL# 56 torezolid phosphate 56 custirsen 56 MT#/MEDI-# 56 KNS # 56 oligonucleotide therapeutics 56 Hematide TM 56 OXi# 56 LNP formulations 56 Hsp# inhibitor 56 Phase Ib study 56 mTOR inhibitors 56 HCV polymerase inhibitors 56 nicotinic 56 AQD class 56 herpetic keratitis 56 histone deacetylase HDAC inhibitors 56 benzimidazole 56 antifibrotic 56 TLR8 agonist 56 renin inhibitor 56 PsychoGenics 56 Isis antisense 56 GRN# 56 Rasagiline 55 otelixizumab 55 Tarvacin TM 55 selective inhibition 55 fosbretabulin 55 XL# XL# XL# XL# 55 NTx TM -# 55 XmAb ® 55 outlicensing 55 leading oral taxane 55 sulodexide 55 mertansine 55 incretin 55 TLR9 agonists 55 lorvotuzumab mertansine 55 efficacy tolerability 55 ocrelizumab 55 hormone LHRH antagonist 55 DXL# 55 cannabinor 55 Memryte 55 lumiliximab 55 telomerase activator 55 PDE inhibitors 55 preclinical compounds 55 Golimumab 55 Regado 55 tanespimycin 55 OvaRex R 55 Homspera TM 55 delta isoform 55 potency selectivity 55 receptor agonists 55 Dalbavancin 55 regenerative stem cell 55 SIRT1 activators 55 Omacetaxine 55 Trizytek 55 tafamidis 55 Prodarsan R 55 COMT inhibitors 55 anti thrombotic 55 orally inhaled migraine 55 HSP# inhibitor 55 mecamylamine 55 novel anticancer 55 ostarine 55 TRV# [001] 55 Aurexis 55 ruxolitinib 55 small molecule tyrosine 55 mGluR2 NAM 55 P#X# antagonist 55 GALNS 55 Panzem R NCD 55 entinostat 55 Virulizin ® 55 Synavive 55 siRNA therapeutics 55 VEGF inhibitors 55 Trophos 55 proteasome inhibitors 55 Traficet EN 55 pregabalin Lyrica 55 vascular disrupting 55 neuro protective 55 inverse agonist 55 anti fibrotic 55 FVIIa 55 TRIOLEX HE# APOPTONE HE# 55 tubulin inhibitor 55 Harbor BioSciences 55 Kosan dependence 55 RNAi therapeutic targeting 55 nitride GaN 55 PORxin TM 55 Fentanyl TAIFUN R 55 DOS# 55 seliciclib CYC# 55 Spiegelmer 55 thetreatment 55 TPI ASM8 55 biologic therapeutics 55 TREANDA 55 Angiocept 55 nonstimulant 55 Safinamide 55 BiTE 55 trastuzumab DM1 T DM1 55 NEUMUNE 55 Interferon beta 55 Ceflatonin 55 ALN TTR# 55 bremelanotide 55 antidiabetic 55 IRX 2 55 immune modulator 55 calcitonin gene related 55 silicon carbide SiC gallium 55 volociximab 55 bortezomib Velcade 55 protein kinase inhibitors 55 Cardio Vascu Grow 55 SGLT inhibitors 55 PI3K/Akt pathway inhibitor 55 epothilones 55 delafloxacin 55 Bendavia 55 OHR/AVR# 55 treating neuropathic pain 55 CYT# potent vascular disrupting 55 Gemzar gemcitabine 55 histone deacetylase inhibitor 55 oral antiviral 55 NTDDS 55 favorable pharmacokinetic 55 registrational 55 maturation inhibitor 55 Vidaza azacitidine 55 HCD# [002] 55 ThGRF 55 Locked Nucleic Acid LNA 55 microtubule inhibitor 55 neuroactive 55 Posiphen 55 JAK3 inhibitor 55 SomatoKine 55 TACI Ig 55 GLP toxicology studies 55 RGB # 55 Ecallantide 55 TriRima 55 Anti angiogenic 55 alkylating agent 55 SPRIX ® 55 PCK# 55 biobetter 55 5 HT2A receptor 55 Bevasiranib 54 novel histone deacetylase 54 NNR Therapeutics 54 p# inhibitor 54 CCX# 54 SERMs 54 AZD# 54 small molecule thrombopoietin 54 Phase IIb clinical trials 54 MEK inhibitor RDEA# 54 CD# CEA 54 EGS# 54 FoldRx 54 non nucleoside 54 tubulin inhibitors 54 drug GAP #B# 54 PI3K inhibitor 54 midstage trials 54 Immunotherapeutic 54 Lauriad 54 potent antiproliferative 54 Lisofylline 54 Chrysalin 54 antithrombotic 54 theranostic 54 SAR# [002] 54 budiodarone 54 Myrexis 54 Vaccinex 54 TOPIGEN 54 mGluR5 negative 54 orally bioavailable 54 HuMax EGFr 54 iSONEP 54 hypoxia activated prodrug 54 Sphingomab 54 vidofludimus 54 Modrenal 54 selective adenosine 54 Ostarine 54 Myolimus 54 Intarcia 54 Sulonex 54 Proellex TM 54 ocular formulation 54 Arcalyst 54 CRD5 54 Dr. Aiping Young 54 APD# 54 GED aPC 54 HSP# inhibitors 54 Cutanea 54 ulimorelin 54 Debio 54 HGS ETR1 54 Aplidin 54 Dual Opioid 54 AzaSite Plus 54 Romidepsin 54 GMX# 54 VitiGam 54 XmAb# 54 bardoxolone methyl 54 therapeutic peptide 54 Trofex 54 LungExpress Dx TM 54 anticancer compound 54 Resten NG 54 ApoB SNALP 54 IL# PE#QQR 54 Ketotransdel TM 54 Pharmos proprietary 54 AAG geldanamycin analog 54 cognitive enhancer 54 immunomodulator 54 immunomodulatory effects 54 Nasdaq IDRA today 54 proprietary transdermal 54 ZFP Therapeutic 54 Fibrillex TM 54 liposomal delivery 54 Ophthotech 54 SGLT2 inhibitors 54 rNAPc2 54 erythropoietic 54 vosaroxin 54 Vascular Endothelial Growth 54 Noxafil 54 Atiprimod 54 GeneICE 54 Chemokine 54 CCR5 antagonist 54 prostones 54 immunomodulatory 54 MDV# 54 Relivar 54 aurora kinase 54 novel VDA molecule 54 tyrosine kinase inhibitor 54 KRN# 54 Mpex 54 compound PMX # 54 Ocrelizumab 54 phase IIb clinical 54 ISIS # 54 VA# [002] 54 preclinical efficacy 54 GPCR targets 54 SinuNase TM 54 DR Cysteamine 54 pradefovir 54 VentiRx 54 ELND-#/AZD-# 54 JAK#/JAK# 54 NovaBay Aganocide compounds 54 BAL# [002] 54 anticancer therapeutics 54 ALN HTT 54 MGd 54 betrixaban 54 MAP# 54 Enkephalin 54 peroxisome proliferator activated 54 NanoCrystal technology 54 TG# [003] 54 XL# anticancer compounds 54 AVN# [001] 54 direct thrombin inhibitors 54 Orphan Drug designations 54 omecamtiv mecarbil 54 ganaxolone 54 investigational therapies 54 peptidic 54 TARIS 54 HDAC inhibition 54 TAFA# 54 neuroprotective 54 pan genotypic 53 BAY #-# 53 IND submission 53 immunological diseases 53 Shigamabs ® 53 methylnaltrexone 53 GLPG# 53 Spiegelmers ® 53 aldehyde dehydrogenase ALDH2 deficiency 53 Metallophile ™ Technology 53 PDE4 modulators 53 VEGF receptor 53 Insegia 53 CDK inhibitors 53 trastuzumab DM1 53 novel peptide 53 squalamine 53 GRN#L 53 ASONEP 53 purinergic receptors P#X# 53 anti CD3 antibody 53 antitumoral 53 peptide therapeutics 53 visilizumab 53 brain penetrant 53 Dual Opioid TM 53 cyclophilin inhibitors 53 including eniluracil ADH 53 Solazed 53 cytoprotective 53 trodusquemine 53 Fc fusion protein 53 BrachySil TM 53 NXL# 53 CCR2 53 uricase 53 ALV# 53 MBP# [001] 53 Hedgehog pathway inhibitor 53 phase IIa clinical 53 Homspera 53 BHT DNA 53 multitargeted 53 personalized immunotherapy 53 targeting CD# 53 ataluren 53 RenaZorb TM 53 BioSilicon 53 immunotherapeutic approaches 53 PDE4 inhibitors 53 Intuniv 53 clinically validated targets 53 activate SIRT1 53 Hsp# inhibitors 53 ALN VSP 53 erlotinib Tarceva ® 53 Miraxion Amarin lead 53 Capesaris 53 receptor inhibitor 53 potently inhibit 53 Ramoplanin 53 clevidipine 53 Lpathomab 53 PANVAC VF 53 LHRH antagonists 53 Protexia R 53 almorexant 53 antidepressive 53 CG# [003] 53 KineMed 53 Cx# [002] 53 PEG PAL 53 cardiotoxic 53 preclinically 53 TRIOLEX 53 Lpath 53 Proxinium TM 53 Receptors GPCRs 53 KL4 surfactant 53 AKT inhibitor 53 crofelemer 53 Anticalin R 53 DCCR 53 novel therapeutic antibodies 53 A3 adenosine receptor 53 vivo validation 53 targeted antifolate 53 EOquin 53 nucleotide analog 53 subtype selective 53 iroxanadine 53 Ambrx 53 NS#/#A protease 53 JAK3 53 L BLP# 53 prokinetic 53 RhuDex ® 53 Pazopanib 53 Phase 1a clinical 53 Hsp# inhibition 53 ZFNs clinical trials 53 dermal patch 53 PEGPH# 53 pharmacokinetics pharmacodynamics 53 DAVANAT 53 muscarinic 53 celgosivir 53 Cancidas 53 humanised monoclonal antibody 53 HCV nucleoside polymerase inhibitors 53 Blinatumomab 53 Interferon alpha 53 Anticalin ® 53 Abiraterone acetate 53 small molecule 53 Anticalins 53 investigational drug 53 IL# PE 53 ReN# 53 novel immunotherapeutic 53 preclinical toxicology 53 LEP ETU 53 Cerashield 53 Amplimexon 53 Phase #b/#a 53 deforolimus 53 immune modulators 53 inhibit platelet function 53 tubulin binding 53 Dr. Marlies Sproll 53 diagnostic molecular imaging 53 Aerosurf 53 systemic RNAi therapeutic 53 Aurora kinase 53 pan HDAC inhibitor 52 Combivir Kivexa 52 Cogane 52 ADME properties 52 SNALP technology 52 Tolerx 52 novel antiviral therapeutics 52 histone deacetylase 52 class mGluR5 inhibitor 52 recombinant factor VIIa 52 PNT# 52 indications Cytokinetics 52 Anaphore 52 Azixa 52 immunoregulation 52 Phase #b/#a clinical 52 velafermin 52 Protectans 52 histone methyltransferases HMTs 52 Carfilzomib 52 butyrylcholinesterase 52 thrombin inhibitor 52 anti neoplastic 52 triterpenoids 52 AZX# 52 CA4P 52 Prednisporin TM 52 urocortin 2 52 GDIR 52 non alcoholic steatohepatitis 52 Virulizin R 52 renin inhibitors 52 ProMune 52 uric acid lowering 52 polymerase inhibitors 52 HDAC Inhibitor 52 deacetylase inhibitors 52 ganetespib 52 HepDirect technology 52 macrolide antibiotics 52 biased ligand 52 HIV integrase inhibitor 52 RNA interference RNAi therapeutics 52 PBT2 52 oral gallium 52 Veronate 52 antiangiogenic 52 anticancer activity 52 Fibroblast Growth Factor Receptor 52 Hemospan 52 blood clot dissolver 52 lintuzumab SGN 52 immunotherapeutics 52 EGFR tyrosine kinase inhibitors 52 sodium stibogluconate 52 antibody MAb 52 Crofelemer 52 vaccine GRNVAC1 52 CobaCyte 52 ZFP TFs 52 Zolinza 52 cancer immunotherapies 52 GAP #B# 52 imexon 52 CRF1 receptor antagonist 52 Novel Anti Inflammatory 52 TKM PLK1 52 Fleximer R 52 neurotrophic 52 antineoplastic agents 52 engineered RAP peptides 52 Menerba 52 long acting bronchodilator 52 chimeric monoclonal antibody 52 cyclophilin inhibitor 52 autoimmune inflammatory 52 bioactive rich adaptogenic 52 Galenea 52 pharmacokinetic interactions 52 dexpramipexole 52 carbohydrate polymer 52 mGluR5 antagonist 52 interferon alpha IFN 52 LentiVector technology 52 SMT C# 52 antimitotic 52 Campath ® 52 phase Ib 52 Intellikine 52 anti infective treatments 52 preclinical studies 52 bexarotene 52 siRNA therapeutic 52 BZL# 52 CRLX# 52 mGluR5 antagonists 52 optimized siRNA 52 antagomirs 52 antitumor 52 quinolone 52 Bioral 52 elesclomol 52 MitoQ 52 Bruton tyrosine kinase Btk 52 topical dermatology 52 AQ4N 52 multicenter Phase II 52 hepatotoxic 52 small molecule agonists 52 Phase Ib clinical 52 antibiofilm 52 Darapladib 52 liprotamase 52 fluoro sorafenib 52 CTA# 52 immunomodulation 52 ddRNAi 52 MoxDuo 52 Pharmos pipeline 52 metabonomics 52 EndoTAG TM 52 pharmacologic agents 52 GSK # 52 Stimuvax R 52 quinoline 52 Cytotoxic 52 Cloretazine R VNP#M 52 Neo Kidney Augment ™ 52 Viprovex TM 52 Phase 2a trial 52 Oral NKTR 52 oral PTH 52 GRNCM1 52 Tranzyme Pharma 52 VEGF Trap 52 investigational compounds 52 refractory APL 52 CD# monoclonal antibody 52 Phase IIB 52 Clioquinol 52 Sym# 52 anionic backbone 52 GLP toxicology 52 effector function 52 potent neuroprotective 52 Anticalins ® 52 irinotecan oxaliplatin 51 orally administered 51 nucleoside analogues 51 TNF alpha antagonist 51 PREOS 51 promising anticancer 51 MOZOBIL 51 anti CD3 51 vivo potency 51 constipation OIC 51 teduglutide 51 DexaSite 51 ELACYT 51 Trofex TM 51 sigma receptors 51 resolvin 51 pertuzumab 51 synthetic cannabinoid compounds 51 ANG# 51 Sangamo ZFP technology 51 AMPK activators 51 Etubics 51 FK# 51 Adenuric R 51 CTLA4 Ig 51 KSP inhibitor 51 vaccine adjuvant 51 EGFR HER 51 mda 7 51 solubilization 51 agonists 51 systemically administered 51 pharmacodynamic 51 Nuvion 51 Charlesson 51 Phase 1b trial 51 include VALSTAR TM 51 Resolvyx 51 enzyme cofactor 51 G Protein Coupled 51 investigational compound 51 NexACT ® 51 Smac mimetics 51 favorable pharmacokinetic profile 51 humanized monoclonal antibodies 51 next generation URAT1 51 HepDirect R 51 #D#C# 51 PREOS R 51 HEPLISAV ™ 51 Gemin X 51 Darinaparsin 51 EndoTAG TM -1 51 immatics 51 recombinant biopharmaceutical 51 PTH analogue 51 PRLX # 51 2 methoxyestradiol #ME#